Notably, several food‐derived bioactive peptides have been reported to possess sEH inhibitory activity, which indicates that identifying colitis regulatory peptides by screening the inhibitory peptides of sEH is considered a promising approach for the treatment of inflammation and related diseases (Yang, 2018). This evidence concerns the gene EPHX2 and colitis.